InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: None

Thursday, 04/03/2014 7:40:27 PM

Thursday, April 03, 2014 7:40:27 PM

Post# of 146240
Puffer, like the idea that the "good doctors", employees, collaborators meet regularly to see where they are in their conservative plan with the idea to surprise the competition, knowing full well they've been given guidance by the FDA and that they can deliver fast, characteristic of NanoViricides, Inc.

A couple of years ago people were posting about NanoViricides, Inc. clinical trials in 5 - 7 years. Today we are on-track to deliver clinical trials Q1 2014.

"...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.


"...by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.



I, and others here, don't wish ill to the NNVC naysayers and that is why I've said, don't get caught by surprise in a turn of events.

GaryR wrote,

Since Ebola and ERASMUS are linked in the news, I wonder if Dr S decided to dust off some of that 6-8 year old Ebolacide that our govt wasnt interested in, throw a couple of vials in his shaveing kit and demo with them this week??? If we got the 'cides and they have the credibility it might just lead to something big, unexpected, and soon. Wouldnt that be fun!





The EU and governments of the African continent, should be the advocates before the U.S. government, for the Ebola Cide (or other nanoviricide(R)). NanoViricides, Inc. should not be held liable in any way for going out of their way to deliver a low-toxicity, safe, and effective therapeutic drug, other than FluCide candidate. On the contrary, 'the small company' should be compensated, handsomely compensated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News